Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Cardiovascular Abnormalities Clinical Trials

A listing of Cardiovascular Abnormalities medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (36) clinical trials

To test the hypothesis that the treatment strategy of left atrial catheter ablation for the purpose of eliminating AF will be superior to current state-of-the-art medical therapy, with either rate control or rhythm control drugs for reducing total mortality Randomized: 1:1

Phase N/A

Prospective, non-randomized, multi-center, single arm, global IDE clinical study to gather data to satisfy FDA requirements for pre-market submission, on safety, performance and effectiveness of the leads.

Phase N/A

Study Description: To access the battery and device longevity of BSC market-approved ICD and CRT-D devices to validate the device survival information presented in BSC Product Performance Report

Phase N/A

Evaluate whether iv Serelaxin (recombinant for peptide hormone H2 serelaxin, vasodilator) is superior to placebo in: reducing CV death or re-hospitalization due to HF and/or renal failure during a follow up period of 180 days reducing worsening HF & symptoms through Day 5 reducing ICU LOS during index hospitalization

Phase N/A

Humanitarian Use for emergent, life-threatening free perforations, aka free contrast extravasations, into the pericardium in native coronary vessels or saphenous vein bypass grafts ≥ 2.75 mm in diameter.

Phase N/A

The study drug reduces CVS events and type 2 Diabetes mellitus in overweight patients

Phase N/A

A nine year study comparing the cardiovascular safety of allopurinol and febuxostat (Uloric) in patients with gout and cardiovascular comorbidities

Phase

A Double-blind, Randomized, Placebo-controlled, Multicenter Study assessing the impact of additional LDL-cholesterol reduction on Major Cardiovascular events when AMG 145 is used in combination with statin therapy in patients with clinically evident Cardiovascular Disease

Phase N/A

We are currently looking for patients with Type 2 Diabetes and vascular disease. This clinical trial consists of approximately 8 visits in the first 12 months over a 6 year study period. Compensation up to $50.00 per visit

Phase

We are seeking patients 18 years of age or older with a history of Osteoarthritis (OA) or Rheumatoid arthritis (RA) and have Cardiovascular disease or risk factors for developing cardiovascular disease.

Phase N/A